| Variable | Overall N = 1541 |
0 lesions N = 1281 |
1 lesion N = 91 |
2–9 lesions N = 81 |
≥10 lesions N = 91 |
p-value2 |
|---|---|---|---|---|---|---|
| Sex | 0.7 | |||||
| Male | 97 (63%) | 79 (62%) | 7 (78%) | 6 (75%) | 5 (56%) | |
| Female | 57 (37%) | 49 (38%) | 2 (22%) | 2 (25%) | 4 (44%) | |
| HIV status | 0.047 | |||||
| HIV− | 136 (88%) | 115 (90%) | 9 (100%) | 5 (63%) | 7 (78%) | |
| HIV+ | 18 (12%) | 13 (10%) | 0 (0%) | 3 (38%) | 2 (22%) | |
| Prior TB history | 0.3 | |||||
| No prior TB | 138 (90%) | 115 (90%) | 9 (100%) | 6 (75%) | 8 (89%) | |
| Prior TB | 16 (10%) | 13 (10%) | 0 (0%) | 2 (25%) | 1 (11%) | |
| Baseline symptoms | 0.2 | |||||
| Asymptomatic | 123 (80%) | 101 (80%) | 9 (100%) | 5 (63%) | 8 (89%) | |
| Symptomatic | 30 (20%) | 26 (20%) | 0 (0%) | 3 (38%) | 1 (11%) | |
| Cavitation | <0.001 | |||||
| Absent | 148 (96%) | 127 (99%) | 9 (100%) | 8 (100%) | 4 (44%) | |
| Present | 6 (3.9%) | 1 (0.8%) | 0 (0%) | 0 (0%) | 5 (56%) | |
| Consolidation | <0.001 | |||||
| Absent | 147 (95%) | 126 (98%) | 9 (100%) | 7 (88%) | 5 (56%) | |
| Present | 7 (4.5%) | 2 (1.6%) | 0 (0%) | 1 (13%) | 4 (44%) | |
| Fibrosis/scarring | <0.001 | |||||
| Absent | 119 (77%) | 106 (83%) | 5 (56%) | 6 (75%) | 2 (22%) | |
| Present | 35 (23%) | 22 (17%) | 4 (44%) | 2 (25%) | 7 (78%) | |
| Calcified granuloma | 0.058 | |||||
| Absent | 146 (95%) | 123 (96%) | 9 (100%) | 6 (75%) | 8 (89%) | |
| Present | 8 (5.2%) | 5 (3.9%) | 0 (0%) | 2 (25%) | 1 (11%) | |
| Bronchiectasis | <0.001 | |||||
| Absent | 135 (88%) | 118 (92%) | 8 (89%) | 5 (63%) | 4 (44%) | |
| Present | 19 (12%) | 10 (7.8%) | 1 (11%) | 3 (38%) | 5 (56%) | |
| Ground-glass opacity | 0.064 | |||||
| Absent | 138 (90%) | 117 (91%) | 8 (89%) | 5 (63%) | 8 (89%) | |
| Present | 16 (10%) | 11 (8.6%) | 1 (11%) | 3 (38%) | 1 (11%) | |
| Tree-in-bud | <0.001 | |||||
| Absent | 147 (95%) | 126 (98%) | 9 (100%) | 7 (88%) | 5 (56%) | |
| Present | 7 (4.5%) | 2 (1.6%) | 0 (0%) | 1 (13%) | 4 (44%) | |
| Pleural thickening | <0.001 | |||||
| Absent | 144 (94%) | 125 (98%) | 9 (100%) | 5 (63%) | 5 (56%) | |
| Present | 10 (6.5%) | 3 (2.3%) | 0 (0%) | 3 (38%) | 4 (44%) | |
| Atelectasis | <0.001 | |||||
| Absent | 149 (97%) | 127 (99%) | 9 (100%) | 7 (88%) | 6 (67%) | |
| Present | 5 (3.2%) | 1 (0.8%) | 0 (0%) | 1 (13%) | 3 (33%) | |
| Pneumothorax | 0.057 | |||||
| Absent | 151 (98%) | 127 (99%) | 9 (100%) | 7 (88%) | 8 (89%) | |
| Present | 3 (1.9%) | 1 (0.8%) | 0 (0%) | 1 (13%) | 1 (11%) | |
| Pleural effusion | 0.11 | |||||
| Absent | 152 (99%) | 127 (99%) | 9 (100%) | 7 (88%) | 9 (100%) | |
| Present | 2 (1.3%) | 1 (0.8%) | 0 (0%) | 1 (13%) | 0 (0%) | |
| Hilar/mediastinal lymphadenopathy | 0.4 | |||||
| Absent | 151 (98%) | 126 (98%) | 9 (100%) | 8 (100%) | 8 (89%) | |
| Present | 3 (1.9%) | 2 (1.6%) | 0 (0%) | 0 (0%) | 1 (11%) | |
| Nodules | <0.001 | |||||
| Absent | 128 (83%) | 128 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| Present | 26 (17%) | 0 (0%) | 9 (100%) | 8 (100%) | 9 (100%) | |
| Multiple lesion types | <0.001 | |||||
| Absent | 124 (81%) | 116 (91%) | 3 (33%) | 4 (50%) | 1 (11%) | |
| Present | 30 (19%) | 12 (9.4%) | 6 (67%) | 4 (50%) | 8 (89%) | |
| 1 n (%) | ||||||
| 2 Fisher’s exact test | ||||||